- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 285/10 - 1,2,5-ThiadiazolesHydrogenated 1,2,5-thiadiazoles
Patent holdings for IPC class C07D 285/10
Total number of patents in this class: 124
10-year publication summary
|
5
|
5
|
7
|
5
|
7
|
7
|
11
|
8
|
14
|
20
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Katholieke Universiteit Leuven | 1283 |
9 |
| Nerio Therapeutics, Inc. | 11 |
9 |
| University of Zurich | 167 |
8 |
| Abbvie Inc. | 1836 |
6 |
| Calico Life Sciences LLC | 111 |
5 |
| Bristol-myers Squibb Company | 4742 |
4 |
| Modernatx, Inc. | 1291 |
4 |
| Kumquat Biosciences Inc. | 84 |
4 |
| Shenzhen Zhongge Biological Technology Co., Ltd. | 53 |
3 |
| Hangzhou Phecdamed Co., Ltd. | 20 |
3 |
| Glaxo Group Limited | 4375 |
2 |
| Novartis AG | 10262 |
2 |
| Janssen Pharmaceutica N.V. | 3168 |
2 |
| Pfizer Inc. | 3386 |
2 |
| Allergan, Inc. | 2167 |
2 |
| Duke University | 3183 |
2 |
| Chatham University | 8 |
2 |
| China Pharmaceutical University | 358 |
2 |
| Korea Research Institute of Chemical Technology | 1469 |
2 |
| Mochida Pharmaceutical Co., Ltd. | 341 |
2 |
| Other owners | 49 |